2023 |
Cns Pharmaceuticals Inc
|
- |
624.3 K |
-24.6 % |
2022 |
Cns Pharmaceuticals Inc
|
President, Chief Executive Officer and Director |
827.9 K |
-2.1 % |
2021 |
Cns Pharmaceuticals Inc
|
- |
845.9 K |
-46.2 % |
2021 |
Cns Pharmaceuticals Inc
|
Chairman of the Board, President and Chief Executive Officer |
845.9 K |
-46.2 % |
2020 |
Cns Pharmaceuticals Inc
|
- |
1.6 M |
28.0 % |
2020 |
Cns Pharmaceuticals Inc
|
- |
1.6 M |
28.0 % |
2020 |
Cns Pharmaceuticals Inc
|
Chairman of the Board and Chief Executive Officer |
1.6 M |
28.0 % |
2019 |
Cns Pharmaceuticals Inc
|
- |
1.2 M |
648.2 % |
2019 |
Cns Pharmaceuticals Inc
|
- |
1.2 M |
648.2 % |
2019 |
Cns Pharmaceuticals Inc
|
Chairman of the Board, President and Chief Executive Officer |
1.2 M |
648.2 % |
2018 |
Cns Pharmaceuticals Inc
|
- |
164.3 K |
83.4 % |
2018 |
Cns Pharmaceuticals Inc
|
- |
164.3 K |
83.4 % |
2018 |
Cns Pharmaceuticals Inc
|
Chairman of the Board and Chief Executive Officer |
164.3 K |
83.4 % |
2017 |
Cns Pharmaceuticals Inc
|
- |
89.6 K |
- |
2017 |
Cns Pharmaceuticals Inc
|
- |
89.6 K |
- |